According to Pfizer’s own study design documents, scientists were concerned about “occupational exposure” to the recently vaccinated test subjects. Under section “8.3.5.3. Occupational Exposure” Pfizer warns that caretakers and close contacts of the recently vaccinated could be exposed to the spike proteins that are translated and synthesized in the cells of the vaccinated. During the clinical trials, Pfizer instructed researchers to monitor for severe adverse events in the vaccinated and in the unvaccinated people who were exposed to the vaccinated. What does “occupational exposure” entail? The mRNA vaccines do not shed live viruses, so what exactly is being transmitted from the vaccinated to the unvaccinated?
 
Given most people in Israel are vaccinated, many COVID cases in hospital are vaccinated. However, the majority (87%) of hospitalised cases are 60 or older. This highlights what’s known about adaptive immunity and vaccine protection — it declines with age.
According to Pfizer’s own study design documents, scientists were concerned about “occupational exposure” to the recently vaccinated test subjects. Under section “8.3.5.3. Occupational Exposure” Pfizer warns that caretakers and close contacts of the recently vaccinated could be exposed to the spike proteins that are translated and synthesized in the cells of the vaccinated. During the clinical trials, Pfizer instructed researchers to monitor for severe adverse events in the vaccinated and in the unvaccinated people who were exposed to the vaccinated. What does “occupational exposure” entail? The mRNA vaccines do not shed live viruses, so what exactly is being transmitted from the vaccinated to the unvaccinated?
 
Given most people in Israel are vaccinated, many COVID cases in hospital are vaccinated. However, the majority (87%) of hospitalised cases are 60 or older. This highlights what’s known about adaptive immunity and vaccine protection — it declines with age.
 

n the negative side, covid vaccines have been associated with thousands of deaths and tens of thousands of serious adverse events. Importantly, such serious vaccine adverse events may affect even young people at low risk of severe covid, thus questioning the risk – benefit ratio in these age groups. Most recently, the German vaccine commission advised against covid vaccination of children under 16, arguing that safety data provided by vaccine manufacturers was not sufficient.

The chart above, provided by the new OpenVAERS mortality dashboard, shows the dramatic increase in reported US post-vaccination deaths in 2021. On the one hand, not all of these deaths were caused by covid vaccines; but on the other hand, there is significant under-reporting and reporting backlog. Thus, the current US figure of about 5,200 deaths is likely an underestimate.

Doctors often aren’t allowed to talk about this topic. For instance, an Austrian emergency doctor who had to save two vaccinees simultaneously and exclaimed that doctors should “stop injecting this crap”, got reported and fired. A German state prosecutor denied autopsies of dead vaccinees, arguing that health authorities had already determined that covid vaccines “are safe”.

To study case reports of severe and fatal covid vaccine adverse events, see Covid Legal (USA), Covid Vaccine Injuries (18+), and The Defender. Moreover, little is still known about the long-term safety and effectiveness of the various types of covid vaccines. In the US, several doctors recently wrote a letter to the FDA asking it to postpone officially licensing any covid vaccines.

https://openvaers.com/covid-data/mortality  sharp rise 2021

Denied autopsies

https://2020news.de/generalstaatsanwalt-stuttgart-will-obduktionen-nach-impfungen-verhindern/

https://thecovidblog.com/

https://www.cdc.gov/media/releases/2021/p0308-vaccinated-guidelines.html

A person is considered fully vaccinated two weeks after receiving the last required dose of vaccine. Although vaccinations are accelerating, CDC estimates that just 9.2% of the U.S. population has been fully vaccinated with a COVID-19 vaccine that the FDA has authorized for emergency use.

99% in hospitals not vaccinated?

 

99 percent?

The Surgeon General’s statement that 99.5 percent of coronavirus deaths are in the unvaccinated materialized out of thin air and dodgy data. It turns out it’s based on math by a couple of Associated Press reporters that involved some crude calculations – the kind done on a bar napkin – looking at reported deaths from COVID in the month of May and some number, perhaps from a CDC report on the number of COVID deaths in the fully vaccinated, which was “about” 150. Since the AP report didn’t source their data, it’s a guessing game to figure out how they came to this factoid that has since been repeated by every leftist media chain and Biden administrator. The reporters did update their story to correct the number of hospital admissions for coronavirus from 853,000 to 107,000, and the percentage of hospitalized people who had been vaccinated to 1.1%, not 0.1%. Since coronavirus cases in the vaccinated are seriously underreported and so are vaccine side-effects and deaths, the 99% number is simply not real.

https://apnews.com/article/coronavirus-pandemic-health-941fcf43d9731c76c16e7354f5d5e187

Breakthrough cases

https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htm#contribAff

https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html

Only 55% are vaccinated in America.

Sep 27 2021

  • Vaccine breakthrough cases are expected. COVID-19 vaccines are effective and are a critical tool to bring the pandemic under control; however, no vaccine is 100% effective at preventing illness. Some fully vaccinated people will get sick, and some will even be hospitalized or die from COVID-19. However, there is evidence that vaccination may make illness less severe for those who are vaccinated and still get sick. The risk of infection, hospitalization, and death are all much lower in vaccinated people compared to unvaccinated.
  • More than 183 million people in the United States have been fully vaccinated as of September 27, 2021. CDC is monitoring these cases among vaccinated persons and evaluating trends in order to better understand who is at risk for severe COVID-19 following vaccine breakthrough infection. Vaccinated people have also experienced asymptomatic infections.
State health departments voluntarily report vaccine breakthrough cases to CDC. On May 1, 2021, after collecting data on thousands of vaccine breakthrough infections, CDC changed the focus of how it uses data from this reporting system. One of the strengths of this system is collecting data on severe cases of vaccine breakthrough COVID-19 since it is likely that most of these types of vaccine breakthrough cases seek medical care and are diagnosed and reported as a COVID-19 case. CDC relies on a variety of additional approaches to comprehensively monitor vaccine impact. Previous data on all vaccine breakthrough cases reported to CDC from January–April 2021 are available.
  • A vaccine breakthrough infection happens when a fully vaccinated person gets infected with COVID-19. People with vaccine breakthrough infections may spread COVID-19 to others.
 
For this surveillance, a vaccine breakthrough infection is defined as the detection of SARS-CoV-2 RNA or antigen in a respiratory specimen collected from a person ≥14 days after receipt of all recommended doses of an FDA-authorized COVID-19 vaccine
An elevated risk for myocarditis among mRNA COVID-19 vaccinees has been observed, particularly in males aged 12–29 years.
( did not include vaccinated from guest shot or anyone who got the shot and sick up until 14 days.  )
COVID-19 case in a fully vaccinated person (i.e., a breakthrough infection) occurred ≥14 days after completion of the primary series of a COVID-19 vaccine with Food and Drug Administration emergency use authorization per CDC’s definition of a fully vaccinated person (https://www.cdc.gov/ coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html). Fully vaccinated persons were those who received a Pfizer-BioNTech or Moderna mRNA vaccine (92%) or the Janssen (Johnson & Johnson) vaccine (8%). A COVID-19 case in a person who was not fully vaccinated occurred when the person did not receive an FDA-authorized COVID-19 vaccine or received less than a complete primary series or if <14 days had elapsed since completing a primary series of an FDA-authorized vaccine before the specimen collection date. This analysis represents the combined impact of the Pfizer-BioNTech, Moderna, and Janssen vaccines, which had different clinical efficacies against confirmed infection (95%, 94%, and 67%, respectively). Information on different FDA-authorized and approved COVID-19 vaccine products, including clinical efficacy is available at https://www.cdc.gov/coronavirus/2019- ncov/vaccines/different-vaccines.html.
¶ A COVID-19–associated hospitalization
The wonky math they used- same report
:
of cases, hospitalizations, or deaths divided by the number of persons either fully vaccinated or not fully vaccinated (obtained by subtracting the number of fully vaccinated persons from total population estimates). Average weekly incidence in each period was age standardized using the 2000 U.S. Census standard population.¶¶ IRRs were calculated by dividing the incidence among persons not fully vaccinated by that among fully vaccinated persons; 95% CIs were calculated to account for variation in weekly rates. To aid interpretation of changes in IRRs, age-standardized crude VE was estimated as (1 – [inci- dence in vaccinated/incidence in unvaccinated]). A sensitivity analysis examined the impact of excluding partially vaccinated persons from IRRs using data available from nine jurisdic- tions. SAS (version 9.4; SAS Institute) and R (version 4.0.3; R Foundation) were used to conduct all analyses. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.***
During April 4–July 17, a total of 569,142 (92%) COVID-19 cases, 34,972 (92%) hospitalizations, and 6,132 (91%) COVID-19–associated deaths were reported among persons not fully vaccinated, and 46,312 (8%) cases, 2,976 (8%) hospitalizations, and 616 (9%) deaths were reported among fully vaccinated persons in the 13 jurisdictions (Table). The weekly prevalence of the SARS-CoV-2 Delta variant increased from <1% to 90% during April 4–July 17. Full vac- cination coverage increased from 19% to 54%; in the final week, coverage ranged by age group from 45% (in persons aged 18–49 years) to 73% (≥65 years).
During April 4–June 19, fully vaccinated persons accounted for 5% of cases, 7% of hospitalizations, and 8% of deaths overall; these percentages were higher during June 20–July 17 (18%, 14%, and 16%, respectively). Using the reported 37% vaccination coverage for the 13 jurisdictions during April 4–June 19 and an assumption of 90% VE, vaccinated persons would have been expected to account for 6% of cases (close to the 5% observed). With 53% coverage reported during June 20–July 17, vaccinated persons were expected to account for 10% of cases at a constant VE of 90%; the observed 18% would have been expected at a lower VE of 80%.
Averaged weekly, age-standardized rates (events per 100,000 persons) were higher among persons not fully vaccinated than among fully vaccinated persons for reported cases (112.3 versus 10.1), hospitalizations (9.1 versus 0.7), and deaths (1.6 versus 0.1) during April 4–June 19, as well as during June 20–July 1
To improve comparability of age-standardized rates across data systems, in 1998, the Secretary of the U.S. Department of Health and Human Services (HHS) issued a policy directing all HHS agencies to use the 2000 Standard Population to age standardize death rates. https://www.cdc.gov/nchs/data/ statnt/statnt20.pdf
*** 45 C.F.R. part 46.102(l)(2), 2
Within each age group, the percentage of vaccinated per- sons among cases, hospitalizations, and deaths increased with increasing vaccination coverage
The change in age-standardized IRRs for cases between the April 4–June 19 and June 20–July 17 periods represented potential changes in crude VE from 91% to 78% for infection, from 92% to 90% for hospitalization, and from 94% to 91% for death (Supplementary Figure 1, https://stacks. cdc.gov/view/cdc/109531). A sensitivity analysis excluding partially vaccinated persons in nine jurisdictions yielded similar trends but higher IRRs and VE estimates for hospitalizations and deaths (Supplementary Table, https://stacks.cdc.gov/view/ cdc/109533). V
Monitoring COVID-19 outcomes in populations over time by vaccination status is facilitated through reliable linkage of COVID-19 case surveillance and vaccination data. However, interpreting state-level variation by week might be challenging, especially for severe outcomes with small numbers. The frame- work used in this analysis allows for comparisons of observed IRRs and percentages of vaccinated cases, hospitalizations, and deaths to expected values. The data might be helpful in com- municating the real-time impact of vaccines (e.g., persons not fully vaccinated having >10 times higher COVID-19 mortality risk) and guiding prevention strategies, such as vaccination and nonpharmacologic interventions.
Same report: delta variant
SARS-CoV-2 variant weighted prevalence estimates are based on whole- genome sequencing results submitted to or performed by CDC (https://covid. cdc.gov/covid-data-tracker/#variant-proportions). By jurisdiction, the SARS- CoV-2 Delta variant surpassed ≥50% prevalence, using unweighted estimates, in the weeks ending June 12, 2021 (one); June 19, 2021 (one); June 26, 2021
§§ (two); and July 3, 2021 (nine). https://www.census.gov/progra
 To ascertain COVID-19–associated hospitalizations, two jurisdictions relied upon case investigations; seven jurisdictions relied upon hospital records; two jurisdictions relied upon both case investigations and hospital records; and two did not submit hospitalization data. Four jurisdictions reported hospitalizations only where COVID-19 was the cause, and seven reported COVID-19 cases in persons hospitalized for any cause.
§ To ascertain COVID-19–associated deaths, eight jurisdictions relied upon vital records, and five jurisdictions relied upon a combination of vital records and provider reporting (two), case investigations and vital records (two), and provider reporting, case investigations, and vital records (one). Eleven jurisdictions provided deaths with COVID-19 as a cause; one provided all deaths that occurred within 30 days of becoming a case (without confirming cause); and one provided deaths confirmed with COVID-19 as a cause or within 60 days of positive specimen collection.
¶ Fully vaccinated persons are those who are ≥14 days postcompletion of the primary series of a COVID-19 vaccine with Food and Drug Administration emergency use authorization. Not fully vaccinated persons are those who did not receive a COVID-19 vaccine with Food and Drug Administration emergency use authorization or who received a COVID-19 vaccine but are not yet considered fully vaccinated.
** Alabama, Arizona, Colorado, Indiana, Los Angeles County (California), Louisiana, Maryland, Minnesota, New Mexico, New York City (New York), North Carolina, Seattle/King County (Washington), and Utah.